Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Daniel Mills

Plastic Surgery Laguna Beach, CA Medical Doctor

NPI 1568550242 CMS profile 207042

31852 PAC Coast Hwy, Suite #401, Laguna Beach, CA 92651

Open in the dashboard

General payments

$109,321

231 records reported · program years 2019–2025

Research payments

$12,675

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$42,245 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Daniel Mills of Laguna Beach, CA is reported in the CMS Open Payments database as having received $109,321 across 231 general payments and $12,675 in research payments paid to them. Separately, studies naming them as principal investigator received $42,245 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,514 35
2024 General $1,140 31
2023 General $14,865 28
2022 General $14,058 43
2021 General $28,021 29
2021 Research $9,925 1
2020 General $4,333 15
2020 Research $2,750 1
2019 General $43,390 50

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Mills
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Daniel Mills were reported at $3,514. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Daniel Mills Plastic Surgery median Middle half National median
2019 $43,390 $371 $122–$1,483 $163
2020 $4,333 $158 $52–$438 $114
2021 $28,021 $249 $87–$752 $132
2022 $14,058 $274 $102–$793 $149
2023 $14,865 $299 $113–$891 $160
2024 $1,140 $361 $124–$1,062 $164
2025 $3,514 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $50,789 73 payments
  2. Davol Inc. $36,797 5 payments
  3. Surgical Specialties Corporation (US), Inc. $6,600 2 payments
  4. TELA Bio, Inc. $4,753 32 payments
  5. Merz North America, Inc. $2,786 21 payments
  6. Motiva USA, LLC $1,955 14 payments
  7. AbbVie, Inc. $1,880 28 payments
  8. Sientra, Inc. $1,133 7 payments
  9. Mentor Worldwide LLC $901 16 payments
  10. Integra LifeSciences Corporation $664 2 payments
  11. Other $1,063 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $49,158 25 payments
  2. Acquisitions $36,665 4 payments
  3. Food and Beverage $11,299 183 payments
  4. Gift $8,187 5 payments
  5. Travel and Lodging $2,600 9 payments
  6. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $750 3 payments
  7. Long term medical supply or device loan $652 1 payment
  8. Education $10 1 payment
Products named General payments · program years 2019–2025
  1. NATRELLE $34,839 33 payments
  2. ALLODERM $11,066 12 payments
  3. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $4,577 29 payments
  4. BOTOX $3,602 7 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $1,855 15 payments
  6. Motiva Implant Matrix $1,783 11 payments
  7. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $1,554 17 payments
  8. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,133 7 payments
  9. MENTOR MemoryGel Resterilizable Gel Sizer $882 15 payments
  10. REVOLVE $864 1 payment
  11. Other $2,128 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Davol Inc. $9,925 1 payment
  2. Sientra, Inc. $2,750 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

40

Median for Plastic Surgery: 39

Drug cost

$433

Median for Plastic Surgery: $219

Branded share of claims

65%

Median for Plastic Surgery: 30%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Moxifloxacin Hcl Generic 14 $281
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $104
Ondansetron Odt Ondansetron Brand 15 $48

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 700 Part D prescribers listed as Plastic Surgery; they describe a distribution and say nothing about conduct.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DAXXIFY
  • REVANCE THERAPEUTICS, INC. $391
$391 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

233 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record